Diabetic eye disease

Macular Disease Foundation Australia (MDFA) has launched Eye Connect, a comprehensive support service for people living with macular disease and...

A new study has found patients prescribed semaglutide for diabetes or weight loss had a higher risk of developing a...

The Australian Therapeutic Goods Administration (TGA) has approved Eylea 8mg, a higher dose of aflibercept for adults with neovascular aged-related...

Specsavers optometrists nationwide have reached one million appointments registered with the KeepSight national diabetes eye check reminder program. This number...

The Centre for Eye Research Australia (CERA) has established Cerulea Clinical Trials, a new specialist ophthalmic clinical trial facility in...

The KeepSight eye check reminder program has registered its 400,000th participant, marking a major milestone in the prevention of diabetes-related...

  Bayer’s high dose aflibercept 8 mg – now approved in the European Union and US – has been labelled...

There is limited evidence on effective care models for diabetic retinopathy in Indigenous Australians, so Rosamond Gilden conducted her own...

  Whether ophthalmologists are scanning a three-month-old or elderly patient, the ability of Optos ultra-widefield imaging devices to capture 200°...

The US FDA has approved the use of high dose Eylea (aflibercept) for three macular conditions, equating to longer intravitreal...